In contrast to the situation in lung cancer, Cx43 is increased with the formation of GJIC in the resistant tumour cells and this increase is induced by epidermal growth factor receptor (EGFR) activated JNK-ERK1/2-AP-1 signalling [176]. This evidence concerns the gene EGFR and lung carcinoma.